Objective Since the term "combined pulmonary fibrosis and emphysema" (CPFE) was first proposed, the co-existence of pulmonary fibrosis and pulmonary emphysema (PE) has drawn considerable attention. However, conflicting results on the clinical characteristics of patients with both pulmonary fibrosis and PE have been published because of the lack of an exact definition of CPFE. The goal of this study was thus to clarify the clinical characteristics and phenotypes of idiopathic interstitial pneumonia (IIP) with PE. Methods We retrospectively analyzed IIP patients who had been admitted to our hospital. Their chest highresolution computed tomography images were classified into two groups according to the presence of PE. We then performed a cluster analysis to identify the phenotypes of IIP patients with PE. Results Forty-four (53.7%) out of 82 patients had at least mild emphysema in their bilateral lungs. The cluster analysis separated the IIP patients with PE into three clusters. The overall survival rate of one cluster that consisted of mainly idiopathic pulmonary fibrosis (IPF) patients was significantly worse than those of the other clusters. Conclusion Three different phenotypes can be identified in IIP patients with PE, and IPF with PE is a distinct clinical phenotype with a poor prognosis.
Introduction
Although pulmonary fibrosis and emphysema had previously been considered to be distinct pulmonary manifestations, it has recently been recognized that pulmonary emphysema (PE) can be present in patients with pulmonary fibrosis (1-3). Since Cottin et al. described combined pulmonary fibrosis and emphysema (CPFE), which is defined by the presence of PE in the upper lobes and pulmonary fibrosis in the basal lungs on a high-resolution computed tomography (HRCT) scan (4), many reports on the clinical characteristics of CPFE have been published.
It has been reported that, in CPFE patients, significantly impaired gas exchange is observed, and the prevalence of pulmonary hypertension (PH) is higher than that in patients with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (5) . PH is more severe in CPFE patients than in those with IPF alone, and the existence of PH is reported to be a poor prognostic factor in CPFE patients (6) , with a one-year survival rate of just 60% (7) . In addition, the results of pulmonary function tests (PFTs) often differ from those of tests performed on patients exhibiting pulmonary fibrosis without PE. Vital capacity (VC) and total lung capacity (TLC) are frequently within the normal range, whereas values for gas exchange and the diffusing capacity of the lung for carbon monoxide (DLCO) are significantly decreased in CPFE patients (8) .
These results suggest that CPFE is a distinct clinical disorder; however, no consensus on its definition has been reached. Although IPF/usual interstitial pneumonia (UIP) seems to be the most common fibrotic pattern in CPFE, even in the report by Cottin et al., some other fibrotic interstitial pneumonia patterns, such as desquamative interstitial pneumonia and organizing pneumonia, were included (4, 9, 10) . On the other hand, in the broadest sense, all types and extents of PE and pulmonary fibrosis could be included in CPFE. In fact, the updated official American Thoracic Society and European Respiratory Society (ATS/ ERS) statement for idiopathic interstitial pneumonias (IIPs) states that CPFE comprises a heterogeneous population of patients (11) . In this setting, conflicting results have been reported. For example, some recent reports have shown no difference in survival between patients with CPFE and IPF (12, 13) . To determine whether CPFE in the broadest sense ("broader" CPFE) can be divided into some phenotypes according to the clinical characteristics, we included various types of PE and fibrosis in order to identify the phenotypes of IIP patients with PE in this study.
Materials and Methods

Study design
We retrospectively analyzed sequential patients with IIP who had been admitted to hospital for clinical evaluation between January 2008 and December 2010. They had had no progression of symptoms such as dyspnea or radiological findings for at least three months. Each diagnosis of IIP was made in accordance with the ATS/ERS guidelines (14) . IPF was diagnosed according to an official statement of the ATS, the ERS, the Japanese Respiratory Society and the Latin American Thoracic Association (15) . Each patient's chest HRCT images were reviewed and IIP patients with PE were selected. The prevalence of PE, clinical characteristics, clinical parameters, comorbidity (incidence of lung cancer), prognosis (period from diagnosis to death as of August, 2012), laboratory data (serum Krebs von den Lungen-6, surfactant protein A, surfactant protein D and brain natriuretic peptide), right ventricular systolic pressure (RVSP) estimated by transthoracic echocardiography and fibrosis/emphysema score on HRCT were analyzed. To identify the phenotypes of patients with PE, we performed a cluster analysis. This study was approved by the Fukushima Medical University Ethics Committee.
Chest computed tomography
All patients underwent chest HRCT, and each HRCT image was reviewed separately by two of the authors without knowledge of the clinical data. We evaluated the presence of fibrosis and PE separately in each patient. The right and left lungs were divided into three portions: an upper portion (apex to aortic arch); a middle portion (aortic arch to inferior pulmonary vein); and a lower portion (inferior pulmonary vein to diaphragm). A score was assigned to describe the amount of lung affected by fibrosis (reticular shadow and honeycombing) or PE in each portion as follows: score 0 (no fibrosis or emphysema); score 1 (mild <25%); score 2 (moderate 25-50%); score 3 (marked 50-75%); and score 4 (severe >75%), as previously reported (16, 17) . The scores for each portion of both lungs (six portions) were summed to obtain a total fibrosis score or emphysema score, with 24 being the maximum possible score. The presence of PE was defined as a total emphysema score of one or more points in each lung. The type of emphysema present was reviewed and defined as previously described (18) . The following patterns were identified: centrilobular emphysema type, in which at least 80% of emphysema present was in a centrilobular pattern; paraseptal emphysema type, in which at least 80% of emphysema present was in a paraseptal pattern; and mixed emphysema type, in which other amounts of centrilobular and paraseptal emphysema were present.
Pulmonary function tests
PFTs were performed according to ATS guidelines (19) . For each patient, alveolar-arterial oxygen difference in an arterial blood gas analysis, VC, FEV1, DLCO, carbon monoxide diffusing capacity adjusted for alveolar volume, residual volume and TLC were recorded.
Echocardiographic evaluation
Transthoracic echocardiograms were performed using a commercially available system. Standard two-dimensional and color Doppler data were digitally saved. RVSP was estimated as previously described (20) . PH was defined as RVSP >40 mmHg.
Clinical phenotypes in IIP with PE by a cluster analysis
To evaluate the clinical significance of PE in IIP, we attempted to identify the clinical phenotypes in IIP patients with PE. A cluster analysis with eight variables -gender (male or female), smoking history (never, former or current smoker), IPF or non-IPF, restrictive respiratory dysfunction, obstructive respiratory dysfunction, pulmonary hypertension (RVSP > 40 mmHg by echocardiography or not), the complication of acute exacerbation after diagnosis and the complication of lung cancer -was performed. These variables were selected according to the clinical characteristics of CPFE, as previously reported (4, 21) . All variables were transformed into a binary format before clustering. Any patients with missing data for any of the selected variables were excluded from the clustering. Then, we compared the characteristics and clinical course of the IIP patients with PE between the identified clusters.
Statistical analysis
Values are presented as the means (standard deviations or ranges), unless otherwise specified. Survival was estimated using the Kaplan-Meier method. All-cause mortality was used in the survival statistics. Surviving patients were censored at the date of last follow-up. Survival was compared using the log-rank test. To identify the clinical phenotypes in IIP patients with emphysema, Ward's minimum-variance 
Results
Clinical characteristics of IIP patients with PE
A total of 86 patients were enrolled. None of the patients met the clinical diagnostic criteria for collagen vascular disease, nor did they have any significant environmental antigen exposure. A surgical lung biopsy was performed for six patients [five patients with UIP and one patient with fibrosing non-specific interstitial pneumonia (NSIP)]. Twelve IPF and four cryptogenic organizing pneumonia (COP) patients were diagnosed according to HRCT and other clinical findings (bronchoalveolar lavage, transbronchial lung biopsy and laboratory data). The remaining 64 patients were categorized as non-IPF because they did not meet the criterion of an HRCT UIP pattern. Among these patients, 24 had typical findings of fibrosing NSIP on HRCT (22, 23) . Four patients, who had COP that had been diagnosed by typical HRCT and clinical findings, were excluded from this study. Therefore, we analyzed a total of 82 IIP patients (17 IPF, 25 fibrosing NSIP and 40 non-IPF/fibrosing NSIP patients).
Forty-four (53.7%) of the 82 patients had PE in their bilateral lungs. HRCT scan images of the IIP patients with and without PE are shown in Fig. 1 . The clinical characteristics of these 44 patients are shown in Table 1 . There were more men (n=37) than women (n=7), and 37 patients (84.1%) had a history of smoking. The mean [range] em- 
Comorbidity and mortality
In the IIP patients with and without PE, the median [95% confidence interval (CI)] follow-up periods were 23.4 (1.0-48.1) and 25.4 (4.0-43.4) months, respectively. We could not identify the comorbidity of one IPF patient with PE. Lung cancer was identified in seven of the 43 IIP patients with PE during follow-up, while no lung cancer was observed in those without PE. There were no significant differences in the incidence of acute exacerbation between these two groups. Mortality was compared between the IIP patients with and without PE (Fig. 2A) . The median survival times from diagnosis were 39.9 (26.1-53.6) and 38.0 months (23.8-52.2) in IIP patients with and without PE, respectively, showing that the presence of PE did not affect mortality in IIP patients. However, when we focused on IPF patients, the presence of PE had a significant impact on mortality; the median survival times were 5.45 (1.53-9.38) and 38.0 months (0-87.3) in IPF patients with and without PE, respectively (p=0.021) (Fig. 2B) . Thirty-five patients with IIP (20 with PE and 15 without PE) died during follow-up. The causes of death were acute exacerbation (6 patients with PE/ 3 without PE), pneumonia (4/5), chronic respiratory failure (4/4), lung cancer (4/0), cardiovascular disease (1/1) and malignant tumors of other organs (1/2).
Cluster analysis of IIP patients with PE
We could not identify the comorbidity of one patient and could not perform an echocardiographic evaluation in two patients. Therefore, the total number of IIP patients with PE analyzed by the cluster analysis was 41. The 41 IIP patients with PE were assigned to three clusters (Fig. 3) . More men were included in Clusters 1 and 2 than in Cluster 3, and all patients with obstructive pulmonary dysfunction were included in Cluster 1. On the other hand, all patients with restrictive pulmonary dysfunction were included in Clusters 2 and 3. IPF patients were exclusively included in Cluster 3. Table 2 shows the characteristics of the IIP patients in each cluster. In PFTs, % predicted VC, FEV1 and TLC were significantly higher in Cluster 1. An evaluation of chest HRCT images revealed that the fibrosis score in Cluster 3 was significantly higher than that in Cluster 1, and the emphysema score in Cluster 1 was significantly higher than that in Cluster 2. From these results, Cluster 1 represents a higher prevalence of obstructive respiratory dysfunction and a lower fibrosis score on chest HRCT. Cluster 2 consists of non-IPF patients with lower VC and a lower emphysema score on HRCT. Cluster 3 mainly consists of IPF patients with lower VC and a higher fibrosis score on HRCT. The prognosis was compared among the three clusters (Fig. 4) , and Cluster 3 had a significantly higher mortality rate (p< 0.005).
Discussion
In this study, PE was identified on HRCT in more than half of the IIP patients. Furthermore, three clusters were identified, and the IPF patients (Cluster 3) had a significantly worse survival rate among the IIP patients with PE.
HRCT findings showed a relatively high prevalence of PE in IIP patients in the present study. The proportions of patients with evidence of PE on a CT scan in the setting of pulmonary fibrosis reported by previous studies ranged from 8 to 50.9% (21, (24) (25) (26) . Compared with these reports, we identified PE in more patients with IIP. Because there is no consensus regarding the severity of PE that should be in-cluded, the varying definitions of PE may have affected the results. In fact, in IIP patients, Todd et al. showed that 54 out of 102 patients (53%) had PE (13) , which is consistent with our results. In their study, an emphysema score of greater than zero, but less than or equal to two was included as 'trivial emphysema', whereas an emphysema score of greater than two was denoted as 'advanced emphysema'. In the present study, there were six 'trivial emphysema' patients.
Since the term CPFE was first described by Cottin et al., the co-existence of PE and fibrosis has drawn considerable attention (4) . However, no consensus on the definition of CPFE has been reached. In some reports, relatively many patients with PE were included because broader CPFE was considered as CPFE (9) . On the other hand, some researchers and clinicians identified CPFE with IPF and upper-lobe PE in the narrowest sense ("strict" CPFE). The lack of a precise definition of CPFE has led to conflicting results being published on the clinical characteristics of CPFE. In this study, we included all types and extents of PE and pulmonary fibrosis, and attempted to determine whether IIP with PE can be divided into some clinical phenotypes. In the cluster analysis, IIP patients with PE were divided into three clusters. Cluster 1 was characterized by a higher prevalence of obstructive respiratory dysfunction and lower HRCT scan fibrosis scores, "Emphysema-dominant type". Cluster 2 consisted of non-IPF patients and was characterized by lower VC and lower HRCT scan emphysema scores, "Non-IPF IPdominant type". Cluster 3 consisted mainly of IPF patients and was characterized by severe restrictive respiratory dysfunction and higher HRCT scan fibrosis scores, "IPF CPFE type". We observed significant differences in survival among these three clusters. These results suggest that survival may be predicted by the clinical phenotype of IIP patients with PE. Although the precise reason(s) for the difference in survival is not clear, the complication of lung cancer might have affected the prognosis of the Cluster 3 IPF CPFE type, as all IPF patients with emphysema were included in Cluster 3, and most non-IPF patients were included in Clusters 1 and 2. In Cluster 3, the prevalence of lung cancer was about threefold higher (4/13, 30.8%) than that in Clusters 1 and 2 (3/28, 10.7%). There has been an intense debate on the clinical importance of the co-existence of interstitial pneumonia and PE. The present study demonstrated that 1) the co-existence of PE with interstitial pneumonia worsened the prognosis in IPF, and 2) the survival rate of Cluster 3 "IPF CPFE type" was significantly worse than those of Clusters 1 and 2. These results suggest that the co-existence of PE is clinically important, especially in IPF, meaning that the "original" CPFE involves a different clinical phenotype from other IIP with PE.
There are some limitations associated with this study. Firstly, only six out of 82 patients had a histopathological diagnosis of IIP. Although the diagnosis of IIP was made in accordance with the ATS/ERS guidelines, patients who had been diagnosed as having IPF comprised a relatively small population in this study compared with those in previous reports. Because a variety of pathologic patterns of pulmonary fibrosis have been reported in conjunction with PE (27) (28) (29) , it may be difficult to diagnose patients as having IPF by HRCT findings. In fact, it has been reported that identifying honeycombing, which is the hallmark of IPF on HRCT, is difficult when PE exists concomitantly (30) . As another limitation, the diagnosis of PH was not made by right heart catheterization in this study. Some reports have pointed out that the estimation of RVSP by echocardiography is frequently inaccurate in lung diseases such as IPF (31) . Finally, there may have been a bias in the study population, particularly for analyzing the phenotypes of IIP patients with PE. There is a possibility that the patients analyzed in the present study do not reflect interstitial pneumonia and PE in the general population.
Despite these limitations, we concluded that three different phenotypes can be identified in IIP patients with PE. Furthermore, IPF patients with PE have a distinct clinical phenotype with a poor prognosis ("strict" CPFE). Because we included not only CPFE, but also other types of PE and fibrosis in this study, the results should be helpful for treating IIP patients with PE in real-world clinical settings.
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